HomeGSK • LON
add
GSK plc
Previous close
GBXÂ 1,640.50
Day range
GBXÂ 1,633.99 - GBXÂ 1,647.00
Year range
GBXÂ 1,302.60 - GBXÂ 1,725.81
Market cap
67.85B GBP
Avg Volume
5.65M
P/E ratio
13.66
Dividend yield
3.54%
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 8.05B | 9.16% |
Operating expense | 3.60B | -5.17% |
Net income | 350.00M | -76.59% |
Net profit margin | 4.35 | -78.54% |
Earnings per share | 0.73 | 183.76% |
EBITDA | 1.87B | 39.82% |
Effective tax rate | -5.01% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.69B | -34.81% |
Total assets | 59.00B | -1.90% |
Total liabilities | 46.21B | -7.67% |
Total equity | 12.80B | — |
Shares outstanding | 4.06B | — |
Price to book | 4.99 | — |
Return on assets | 6.84% | — |
Return on capital | 12.75% | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 350.00M | -76.59% |
Cash from operations | 3.20B | 67.77% |
Cash from investing | 268.00M | 149.63% |
Cash from financing | -3.59B | -168.46% |
Net change in cash | -162.00M | -321.92% |
Free cash flow | 3.39B | 100.63% |
About
GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
GSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of February 2024, it had a market capitalisation of £69 billion, the eighth largest on the London Stock Exchange.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Legacy products developed at GSK include several listed in the World Health Organization's List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine and zidovudine. Wikipedia
Founded
Dec 27, 2000
Website
Employees
70,212
